Lysyl Oxidase is Associated with Increased Thrombosis and Platelet Reactivity

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2016 Jan 13

PMID 26755713

Citations 23

Authors

Shinobu Matsuura

Rongjuan Mi

Milka Koupenova

Alexia Eliades

Shenia Patterson

Paul Toselli

Jonathan Thon

Joseph E Italiano Jr

Philip C Trackman

Nikolaos Papadantonakis

Katya Ravid

Affiliations

Soon will be listed here.

Abstract

Lysyl oxidase (LOX) is overexpressed in various pathologies associated with thrombosis, such as arterial stenosis and myeloproliferative neoplasms (MPNs). LOX is elevated in the megakaryocytic lineage of mouse models of MPNs and in patients with MPNs. To gain insight into the role of LOX in thrombosis and platelet function without compounding the influences of other pathologies, transgenic mice expressing LOX in wild-type megakaryocytes and platelets (Pf4-Lox(tg/tg)) were generated. Pf4-Lox(tg/tg) mice had a normal number of platelets; however, time to vessel occlusion after endothelial injury was significantly shorter in Pf4-Lox(tg/tg) mice, indicating a higher propensity for thrombus formation in vivo. Exploring underlying mechanisms, we found that Pf4-Lox(tg/tg) platelets adhere better to collagen and have greater aggregation response to lower doses of collagen compared with controls. Platelet activation in response to the ligand for collagen receptor glycoprotein VI (cross-linked collagen-related peptide) was unaffected. However, the higher affinity of Pf4-Lox(tg/tg) platelets to the collagen sequence GFOGER implies that the collagen receptor integrin α2β1 is affected by LOX. Taken together, our findings demonstrate that LOX enhances platelet activation and thrombosis.

Citing Articles

Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications-A Narrative Review.

Todor S, Ichim C, Boicean A, Mihaila R Curr Issues Mol Biol. 2024; 46(8):8407-8423.

PMID: 39194713 PMC: 11353264. DOI: 10.3390/cimb46080496.

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.

Hasselbalch H, Junker P, Skov V, Kjaer L, Knudsen T, Larsen M Cancers (Basel). 2023; 15(17).

PMID: 37686599 PMC: 10486581. DOI: 10.3390/cancers15174323.

Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer's disease.

Kelly L, Sharp M, Thomas I, Brown C, Schrag M, Antunes L Cereb Circ Cogn Behav. 2023; 5:100171.

PMID: 37457664 PMC: 10338210. DOI: 10.1016/j.cccb.2023.100171.

Cardiovascular Disease in Myeloproliferative Neoplasms: State-of-the-Art Review.

Leiva O, Hobbs G, Ravid K, Libby P JACC CardioOncol. 2022; 4(2):166-182.

PMID: 35818539 PMC: 9270630. DOI: 10.1016/j.jaccao.2022.04.002.

Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population.

Kumari S, Patro A, Mishra B, Kumar Jena S, Singh S Diagnostics (Basel). 2022; 12(1).

PMID: 35054220 PMC: 8774920. DOI: 10.3390/diagnostics12010053.

References

Yang Z, Xiaohua W, Lei J, Ruoyun T, Mingxia X, Weichun H . Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells. Am J Physiol Renal Physiol. 2010; 299(2):F336-46. DOI: 10.1152/ajprenal.00053.2010. View

Nuthakki V, Fleser P, Malinzak L, Seymour M, Callahan R, Bendick P . Lysyl oxidase expression in a rat model of arterial balloon injury. J Vasc Surg. 2004; 40(1):123-9. DOI: 10.1016/j.jvs.2004.02.028. View

Kleppe M, Kwak M, Koppikar P, Riester M, Keller M, Bastian L . JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response. Cancer Discov. 2015; 5(3):316-31. PMC: 4355105. DOI: 10.1158/2159-8290.CD-14-0736. View

Tavil Y, Sen N, Yazici H, Turfan M, Hizal F, Cengel A . Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. Platelets. 2010; 21(5):368-72. DOI: 10.3109/09537101003628421. View

Boitano A, de Lichtervelde L, Snead J, Cooke M, Schultz P . An image-based screen identifies a small molecule regulator of megakaryopoiesis. Proc Natl Acad Sci U S A. 2012; 109(35):14019-23. PMC: 3435220. DOI: 10.1073/pnas.1212545109. View

Landolfi R, Ciabattoni G, Patrignani P, Castellana M, Pogliani E, Bizzi B . Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood. 1992; 80(8):1965-71. View

Arellano-Rodrigo E, Alvarez-Larran A, Reverter J, Colomer D, Villamor N, Bellosillo B . Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. Am J Hematol. 2008; 84(2):102-8. DOI: 10.1002/ajh.21338. View

Falanga A, Marchetti M, Vignoli A, Balducci D, Barbui T . Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol. 2005; 33(5):523-30. DOI: 10.1016/j.exphem.2005.01.015. View

Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff D, Ruggeri Z . Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost. 2006; 4(9):2014-21. DOI: 10.1111/j.1538-7836.2006.02086.x. View

10.

Inoue O, Suzuki-Inoue K, Dean W, Frampton J, Watson S . Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J Cell Biol. 2003; 160(5):769-80. PMC: 2173361. DOI: 10.1083/jcb.200208043. View

11.

Knight C, Morton L, Onley D, Peachey A, Ichinohe T, Okuma M . Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res. 1999; 41(2):450-7. DOI: 10.1016/s0008-6363(98)00306-x. View

12.

Vannucchi A, Pancrazzi A, Guglielmelli P, Di Lollo S, Bogani C, Baroni G . Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. Am J Pathol. 2005; 167(3):849-58. PMC: 1698737. DOI: 10.1016/S0002-9440(10)62056-1. View

13.

Li W, McIntyre T, Silverstein R . Ferric chloride-induced murine carotid arterial injury: A model of redox pathology. Redox Biol. 2014; 1:50-5. PMC: 4116643. DOI: 10.1016/j.redox.2012.11.001. View

14.

Rivera J, Lozano M, Navarro-Nunez L, Vicente V . Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica. 2009; 94(5):700-11. PMC: 2675683. DOI: 10.3324/haematol.2008.003178. View

15.

Eliades A, Papadantonakis N, Bhupatiraju A, Burridge K, Johnston-Cox H, Migliaccio A . Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J Biol Chem. 2011; 286(31):27630-8. PMC: 3149354. DOI: 10.1074/jbc.M111.243113. View

16.

Tadmor T, Bejar J, Attias D, Mischenko E, Sabo E, Neufeld G . The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms. Am J Hematol. 2013; 88(5):355-8. DOI: 10.1002/ajh.23409. View

17.

Vannucchi A, Bianchi L, Cellai C, Paoletti F, Rana R, Lorenzini R . Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood. 2002; 100(4):1123-32. DOI: 10.1182/blood-2002-06-1913. View

18.

Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R . Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J. 2001; 20(9):2120-30. PMC: 125246. DOI: 10.1093/emboj/20.9.2120. View

19.

Shivdasani R, Fujiwara Y, McDevitt M, Orkin S . A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997; 16(13):3965-73. PMC: 1170020. DOI: 10.1093/emboj/16.13.3965. View

20.

Nangalia J, Massie C, Baxter E, Nice F, Gundem G, Wedge D . Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013; 369(25):2391-2405. PMC: 3966280. DOI: 10.1056/NEJMoa1312542. View